Medicare Enrolled
Dr. Ramzi Khairallah, MD
Rheumatology · Syracuse, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khairallah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khairallah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khairallah
Dr. Ramzi Khairallah is a rheumatology specialist in Syracuse, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khairallah performed 175,937 Medicare services across 9,495 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khairallah received a total of $2,045 from 18 pharmaceutical and/or device companies across 48 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khairallah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in NY
$2,045 industry payments
Medicare Practice Summary
Medicare Utilization ↗175,937
Medicare services
Top 1% in NY for rheumatology
9,495
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9,260 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 75,600 | $5 | $9 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
26,660 | $26 | $75 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
23,735 | $34 | $63 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
21,591 | $10 | $32 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
5,499 | $63 | $140 |
| Belimumab injection, 10 mg An injection of belimumab, a medication administered at a dose of 10 mg. |
4,643 | $40 | $56 |
| Infliximab-axxq biosimilar injection, 10 mg An injection of infliximab-axxq, a biosimilar medication, administered in a 10 mg dose. |
1,770 | $23 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,332 | $88 | $165 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,271 | $8 | $10 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
1,203 | $5 | $25 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
1,201 | $3 | $15 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
1,186 | $1 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,169 | $8 | $20 |
| Liver enzyme (SGOT) level test A blood test that measures the level of the liver enzyme SGOT to help assess liver health. |
1,149 | $5 | $15 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
1,148 | $5 | $15 |
| Liver enzyme (SGPT) level test A blood test that measures the level of the liver enzyme SGPT to assess liver function. |
1,145 | $5 | $15 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
1,101 | $4 | $15 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
750 | $95 | $325 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
633 | $21 | $100 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
431 | $46 | $200 |
| Albumin level test A blood test that measures the amount of albumin, a protein made by the liver, in your body. |
424 | $5 | $15 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
416 | $18 | $35 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
253 | $12 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
194 | $61 | $155 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
151 | $132 | $200 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
139 | $9 | $18 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
125 | $13 | $35 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
120 | $4 | $15 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
91 | $28 | $100 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
90 | $10 | $65 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
87 | $4 | $10 |
| Autoimmune disorder antibody titer test A blood test that measures the level of specific antibodies to help assess autoimmune disorders. |
71 | $11 | $55 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
68 | $6 | $15 |
| Hepatitis B surface antigen neutralization test A laboratory test using immunoassay techniques to detect the neutralization of the hepatitis B surface antigen. |
57 | $10 | $25 |
| Hepatitis C antibody test A blood test that checks for antibodies to the hepatitis C virus. This test helps determine if a person has been exposed to the virus. |
53 | $14 | $35 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
51 | $13 | $35 |
| Rheumatoid factor level | 51 | $6 | $35 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
31 | $3 | $10 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
30 | $1 | $15 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 30 | $12 | $15 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
29 | $24 | $55 |
| X-ray of entire middle and lower spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the entire middle and lower spine to visualize the bones and structures in these areas. |
27 | $55 | $105 |
| New patient office visit, complex (60-74 min) | 26 | $158 | $290 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
26 | $20 | $20 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
22 | $34 | $35 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
18 | $5 | $15 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
14 | $37 | $150 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
14 | $15 | $85 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $121 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
42.3% high complexity
50.4% medium
7.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,045
Total received (2018-2024)
Avg $409/year across 5 years
Bottom 49% in NY for rheumatology
18
Companies
48
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,799 (87.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$247 (12.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$431
2023
$424
2022
$378
2021
$387
2018
$425
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$140
UCB, Inc.
$96
Janssen Biotech, Inc.
$85
Fresenius Kabi USA, LLC
$30
Amgen Inc.
$24
Kiniksa Pharmaceuticals International, plc
$19
WERFEN USA LLC
$19
SCILEX PHARMACEUTICALS INC.
$18
Top 3 companies account for 74.5% of 2024 payments
All-time payments by company (2018-2024) ›
Aurinia Pharma U.S., Inc.
$307
Amgen Inc.
$271
Horizon Therapeutics plc
$245
Celgene Corporation
$216
Janssen Biotech, Inc.
$170
AstraZeneca Pharmaceuticals LP
$164
Boehringer Ingelheim Pharmaceuticals, Inc.
$140
Genentech USA, Inc.
$126
Actelion Pharmaceuticals US, Inc.
$107
UCB, Inc.
$96
Lilly USA, LLC
$75
Fresenius Kabi USA, LLC
$30
Kiniksa Pharmaceuticals International, plc
$19
WERFEN USA LLC
$19
PFIZER INC.
$18
SCILEX PHARMACEUTICALS INC.
$18
ABBVIE INC.
$12
AbbVie, Inc.
$11
Top 3 companies account for 40.3% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · Actemra · Arcalyst · Bimzelx · Enbrel · GLOPERBA · Humira · KRYSTEXXA · LUPKYNIS · Otezla · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · TALTZ · TAVNEOS · TREMFYA · Tavneos · UPTRAVI · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
13
Per 100K population
2.8
County median income
$74,740
Nearest hospital
CROUSE HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khairallah is a mixed practice specialist, with above-average Medicare volume (top 1% in NY), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khairallah experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Khairallah performed 75,600 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khairallah receive payments from pharmaceutical companies?
Yes. Dr. Khairallah received a total of $2,045 from 18 companies across 48 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khairallah's costs compare to other rheumatologists in Syracuse?
Dr. Khairallah's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khairallah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Syracuse
Browse rheumatologists in Syracuse ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NY
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NY
Which NY rheumatologists receive the most from drug and device companies.
By company
Aurinia Pharma U.S., Inc. Payments to Doctors
See all physicians who received payments from Aurinia Pharma U.S., Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology